Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Invest Dermatol. 2012 Jan 5;132(3 0 2):785–796. doi: 10.1038/jid.2011.426

Table 1.

COMPARISON OF FEATURES OF XERODERMA PIGMENTOSUM, TRICHOTHIODYSTROPHY AND COCKAYNE SYNDROME

FEATURE XERODERMA
PIGMENTOSUM
(XP)
XP WITH
NEUROLGIC
ABNORMALITIES
TRICHOTHIO-
DYSTROPHY
(TTD)
COCKAYNE
SYNDROME
(CS)
XP/CS
COMPLEX
SKIN
Skin sun sensitivity yes severe yes / no yes yes
Lentiginous skin pigmentation yes yes no no yes
Sunlight - induced skin cancer yes yes no no yes
EYES
Photophobia yes yes yes/ no yes yes
Conjunctival growths yes yes no no yes
Cancer (anterior eye / lids) yes yes no no not reported
Congenital cataracts no no yes yes no
Pigmentary retinal degeneration no no no yes yes
SOMATIC
Short stature no no / yes yes yes yes
Immature sexual development no no no / yes yes yes
NERVOUS SYSTEM
Progressive sensorineural deafness no yes no yes yes
Developmental delay no yes yes yes yes
Progressive neurological degeneration no yes unknown yes yes
Primary neuronal degeneration no yes no no no
Dysmyelination of brain no no yes yes yes
Cerebral atrophy no yes no/ yes yes yes
Cerebellar atrophy no yes no yes yes
Calcifiation (basal ganglia) no no no/ yes yes yes
DISEASE MECHANISM
Reaction to exogenous or endogenous DNA damaging agents yes - severe yes - severe no yes yes
Developmental defect no yes yes - severe yes - severe yes - severe
Nucleotide excision repair defect yes yes yes yes yes
Molecular defects XPA, XPC, XPD, XPE, XPF, XPG, XP VARIANT (POLH) XPA, XPB, XPD, XPF, XPG XPB, XPD, TTDA, TTDN1 CSA, CSB XPB, XPD, XPG